Dongguang, China

Yan Jiang

This inventor holds 1 USPTO granted patent. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yan Jiang. Retrieved from https://idiyas.com/inventor/yan-jiang-97p7rbh7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yan Jiang - Innovator in Antibody Development

Introduction

Yan Jiang is a prominent inventor based in Dongguang, China. She has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. Her work is crucial in advancing therapeutic options for various medical conditions.

Latest Patents

Yan Jiang holds a patent for "Humanized Anti-TRKA Antibodies and Uses Thereof." This patent represents her commitment to creating effective treatments that can improve patient outcomes. The innovation encapsulates her expertise in antibody engineering and therapeutic applications.

Career Highlights

Yan Jiang is currently employed at Sunshine Lake Pharma Co., Ltd. Her role at the company allows her to leverage her skills in research and development. She has been instrumental in driving projects that focus on novel therapeutic solutions.

Collaborations

Yan has collaborated with notable colleagues, including Zhiheng Ren and Junji Dong. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Yan Jiang is a dedicated inventor whose work in antibody development is paving the way for new medical therapies. Her contributions are vital to the ongoing advancements in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…